FDA Approved: DEFERASIROX — Original Application (NorthStar Rx LLC)

View source ↗

Summary

FDA approves NorthStar Rx LLC's original generic application for deferasirox, a once-daily oral iron chelator for reducing chronic iron overload in patients rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Overload
• Iron Overload Due to Transfusion-dependent Anemia
• Transfusional Iron Overload

Drugs mentioned

• Deferasirox (Deferasirox)

Snippet

ORIG AP for DEFERASIROX (DEFERASIROX)